-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illness
Original Research
(1463) Views (518) Full article downloads
Authors: April D Miller, Leslie M Phillips, Richard M Schulz, et al
Published Date August 2010
Volume 2010:2 Pages 143 - 148
DOI: http://dx.doi.org/10.2147/CPAA.S11259
April D Miller1, Leslie M Phillips2, Richard M Schulz1, P Brandon Bookstaver1, Celeste N Rudisill11Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy – University of South Carolina Campus, Columbia, SC, USA; 2Palmetto Health Richland, At the time of writing, Dr Phillips was a PharmD candidate at the University of South Carolina, SC, USA
Introduction: Hospital patients recovering from critical illness on general floors often receive insulin therapy based on protocols designed for patients admitted directly to general floors. The objective of this study is to compare glycemic control and insulin dosing in patients recovering from critical illness and those without prior critical illness.
Methods: Medical record review of blood glucose measurements and insulin dosing in 25 patients under general ward care while transitioning from the intensive care unit (transition group) and 25 patients admitted directly to the floor (direct floor group).
Results: Average blood glucose did not differ significantly between groups (transition group 9.49 mmol/L, direct floor group 9.6 mmol/L; P = 0.83). Significant differences in insulin requirements were observed between groups with average daily doses of 55.9 units in patients transitioning from the intensive care unit (ICU) versus 25.6 units in the direct floor group (P = 0.004).
Conclusions: Patients recovering from critical illness required significantly larger doses of insulin than those patients admitted directly to the floor. Managing insulin therapy in patients transitioning from the ICU may require greater insulin doses.
Keywords: hyperglycemia, glycemic control, insulin, critical illness
Other articles by Dr April D Miller
Intravenous lipid emulsion for treatment of local anesthetic toxicity
Readers of this article also read:
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
ABO and rhesus blood group distribution in Kurds
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Methemoglobinemia due to topical pharyngeal anesthesia during endoscopic procedures
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




